Repros Therapeutics, Inc. (RPRX)

[spartex]

Bio_Pete, I've learned from a number of other people (from message boards of stocks I follow) that during expiration stocks will gravitate to the strike price which benefits those who have sold calls and/or puts. I haven't noticed RPRX following this pattern at all the past few months, so I didn't give it much attention. Plus, they have news pending in May sometime soon. It wasn't until I noticed RPRX dropping on low volume (below 13) and heading towards 12.5 that the options expiration was going to have an effect. I agree, it would have been nice selling some in the low 13's, and buying back in the low 12's a few days later. Why not!

Haven't bought any AIS yet, but I'm following them. Thanks also for your other names...which I will put on my stocks to watch (hope they recover!). I am only holding around 5 biotechs at the moment and try to keep it focused as I find it too hard to track more than 5 at a time closely, as well as a list of new candidates. Currently RPRX, DNDN (sold 1/2 my position at 21's!), REGN, GNVC, and a little SGEN.

I agree with your estimate for current fair value of RPRX, and this is in line with rfj's valuation. May the next few PR's put this all to rest.